Photocure to Present at Two Healthcare-Focused Investor Conferences in April
Press Release – Oslo, Norway, 6 April 2021, Photocure ASA (OSE: PHO), The Bladder Cancer Company, announces that President and Chief Executive Officer, Daniel Schneider and Chief Financial Officer, Erik Dahl are scheduled to present corporate overviews at two upcoming Healthcare Conferences in April.
Presentation details are as follows:
Solebury Trout European Biotech Investor Day: on April 7, 2021, Photocure presents at 7:30pm CET / 1:30pm ET followed by individual investor meetings. This virtual conference sponsored by Goodwin, Solebury Trout, Deutsche Bank and NASDAQ showcases European biotech & healthcare companies.
You can sign up for the webcast here.
Needham Annual Healthcare Conference: on April 15, 2021, Photocure presents at 2:45pm CET / 8:45am ET followed by individual investor meetings. This 20th annual conference is sponsored by the U.S. bank Needham & Company.
Access to the live event/webcast is available here.
For further information, please contact:
Dan Schneider
President and CEO
Photocure ASA
Tel: + 1-609 759-6515
Email: ds@photocure.com
Erik Dahl
Chief Financial Officer
Tel: +47 450 55 000
Email: ed@photocure.no
David Moskowitz
Head of Investor Relations
Tel: +1 202 280 0888
Email: david.moskowitz@photocure.com
Media Enquiries:
Geir Bjørlo
Corporate Communications (Norway)
Tel: +47 91540000
Email: geir.bjorlo@corpcom.no
About Photocure
Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, making cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com, www.hexvix.com, www.cysview.com